Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

Παρόμοια τεκμήρια

• Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
  ανά: Adsit, Sandra, κ.ά.
  Έκδοση: (2017)
• Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies
  ανά: Menter, Alan, κ.ά.
  Έκδοση: (2016)
• Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
  ανά: Pariser, David, κ.ά.
  Έκδοση: (2017)
• Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies
  ανά: Kircik, Leon, κ.ά.
  Έκδοση: (2016)
• Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
  ανά: Alessio Gambardella
  Έκδοση: (2019-09-01)